If you invested in GlaxoSmithKline, Roche or Novartis a year ago, pat yourself on the back. Either you were lucky, prescient or in on the scheme. You and your companies have made a killing. The stock prices of these companies were in a precipitous slide at the end of March 2009, and have each almost—or even more than—doubled since, thanks to the multi-billion dollar injections they received from government.
Aside from an occasional public service announcement there is almost no mention of swine flu—or H1N1—in the media today. No more Kathleen Sebelius telling you to cough into your bent arm, no more government hucksters urging you get vaccinated. As we approach the one-year anniversary of the first outbreaks let’s look at what we’ve learned… More »
No comments:
Post a Comment